Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations

The prevalence of obesity in Asia is of epidemic proportions, with an estimated 1 billion overweight/obese individuals in the region. The majority of patients with type 2 diabetes mellitus (T2DM) are overweight/obese, which increases the risk of cardiorenal outcomes in these patients; hence, sustain...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Metab J
Auteurs principaux: Sheu, Wayne Huey-Herng, Chan, Siew Pheng, Matawaran, Bien J., Deerochanawong, Chaicharn, Mithal, Ambrish, Chan, Juliana, Suastika, Ketut, Khoo, Chin Meng, Nguyen, Huu Man, Linong, Ji, Luk, Andrea, Yoon, Kun-Ho
Format: Artigo
Langue:Inglês
Publié: Korean Diabetes Association 2020
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043991/
https://ncbi.nlm.nih.gov/pubmed/32097996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2019.0208
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires